peptidoform_id	histogram_notes	cleaned_protein_IDs	protein_notes	Entry.Name	Protein.names	Gene.Names	Organism	Length	Signal.peptide	Intramembrane	Subcellular.location..CC.	Transmembrane	Post.translational.modification	neXtProt	RefSeq
ELEHNAEETYGENDENTDDKNNDGEEQEVR_T181_1	convincing	O00461	convincing; golgi membrane	GOLI4_HUMAN	"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)"	GOLIM4 GIMPC GOLPH4 GPP130	Homo sapiens (Human)	696			"SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Endosome membrane; Single-pass type II membrane protein. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Localizes to cis and medial Golgi cisternae. Probably cycles between early Golgi and distal compartments like endosome."	TRANSMEM 13..33; /note=Helical; Signal-anchor for type II membrane protein; /evidence=ECO:0000255	PTM: Phosphorylated probably by c-AMP-dependent kinases in its lumenal part. {ECO:0000269|PubMed:9201717}.; PTM: O-glycosylated; modified by sialic acid residues. {ECO:0000250}.; PTM: N-glycosylated; N-glycans are probably of the complex type and modified by sialic acid residues. {ECO:0000269|PubMed:9201717}.	NX_O00461;	NP_055313.1; NM_014498.4.;
ELEHNAEETYGENDENTDDKNNDGEEQEVR_Y243_1	convincing	O00461	convincing; golgi membrane	GOLI4_HUMAN	"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)"	GOLIM4 GIMPC GOLPH4 GPP130	Homo sapiens (Human)	696			"SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane; Single-pass type II membrane protein. Endosome membrane; Single-pass type II membrane protein. Membrane {ECO:0000305}; Lipid-anchor {ECO:0000305}. Note=Localizes to cis and medial Golgi cisternae. Probably cycles between early Golgi and distal compartments like endosome."	TRANSMEM 13..33; /note=Helical; Signal-anchor for type II membrane protein; /evidence=ECO:0000255	PTM: Phosphorylated probably by c-AMP-dependent kinases in its lumenal part. {ECO:0000269|PubMed:9201717}.; PTM: O-glycosylated; modified by sialic acid residues. {ECO:0000250}.; PTM: N-glycosylated; N-glycans are probably of the complex type and modified by sialic acid residues. {ECO:0000269|PubMed:9201717}.	NX_O00461;	NP_055313.1; NM_014498.4.;
MSNYSLLSVDYVVDK_M147_1_S167_1_Y243_1	convincing	Q06520	convincing; sulfotransferase	ST2A1_HUMAN	Sulfotransferase 2A1 (ST2A1) (EC 2.8.2.2) (Bile salt sulfotransferase) (EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase) (DHEA-ST) (DHEA-ST8) (Hydroxysteroid Sulfotransferase) (HST) (ST2) (SULT2A3)	SULT2A1 HST STD	Homo sapiens (Human)	285			SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:2268288}.		PTM: The N-terminus is blocked.	NX_Q06520;	NP_003158.2; NM_003167.3.;
nATWLSLFSSEESNLGANNYDDYR_n230_1_S167_3	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."				
nEDSMDMDMSPLRPQNYLFGCELK_E111_1_n145_1_S167_2	"mass a bit off for peaks, but maybe"	P06748	likely not sY; nucleus	NPM_HUMAN	Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin)	NPM1 NPM	Homo sapiens (Human)	294			"SUBCELLULAR LOCATION: Nucleus, nucleolus {ECO:0000269|PubMed:19208757, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25818168, ECO:0000269|PubMed:25956029}. Nucleus, nucleoplasm {ECO:0000269|PubMed:25818168}. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome {ECO:0000269|PubMed:14654843}. Note=Generally nucleolar, but is translocated to the nucleoplasm in case of serum starvation or treatment with anticancer drugs. Has been found in the cytoplasm in patients with primary acute myelogenous leukemia (AML), but not with secondary AML. Can shuttle between cytoplasm and nucleus. Co- localizes with the methylated form of RPS10 in the granular component (GC) region of the nucleolus. Colocalized with nucleolin and APEX1 in nucleoli. Isoform 1 of NEK2 is required for its localization to the centrosome during mitosis."		"PTM: Acetylated at C-terminal lysine residues, thereby increasing affinity to histones. {ECO:0000269|PubMed:16107701, ECO:0000269|Ref.17}.; PTM: ADP-ribosylated.; PTM: Phosphorylated at Ser-4 by PLK1 and PLK2. Phosphorylation at Ser-4 by PLK2 in S phase is required for centriole duplication and is sufficient to trigger centriole replication. Phosphorylation at Ser-4 by PLK1 takes place during mitosis. Phosphorylated by CDK2 at Ser-125 and Thr-199. Phosphorylation at Thr-199 may trigger initiation of centrosome duplication. Phosphorylated by CDK1 at Thr-199, Thr-219, Thr-234 and Thr-237 during cell mitosis. When these four sites are phosphorated, RNA-binding activity seem to be abolished. May be phosphorylated at Ser-70 by NEK2. The Thr-199 phosphorylated form has higher affinity for ROCK2. CDK6 triggers Thr-199 phosphorylation when complexed to Kaposi's sarcoma herpesvirus (KSHV) V-cyclin, leading to viral reactivation by reducing viral LANA levels. {ECO:0000269|PubMed:11051553, ECO:0000269|PubMed:12058066, ECO:0000269|PubMed:12882984, ECO:0000269|PubMed:15190079, ECO:0000269|PubMed:15388344, ECO:0000269|PubMed:20333249, ECO:0000269|PubMed:20352051, ECO:0000269|Ref.17}.; PTM: Sumoylated by ARF. {ECO:0000269|PubMed:15897463}.; PTM: Ubiquitinated. Ubiquitination leads to proteasomal degradation. Deubiquitinated by USP36 (PubMed:19208757). {ECO:0000269|PubMed:19208757, ECO:0000269|PubMed:25818168}."	NX_P06748;	NP_001032827.1; NM_001037738.2. [P06748-3];NP_002511.1; NM_002520.6. [P06748-1];NP_954654.1; NM_199185.3. [P06748-2];
nGDVFTMPEDEYTVYDDGEEK_M147_1_n230_1_T181_1_Y243_1	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."		"PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17558413, ECO:0000269|PubMed:2479556, ECO:0000269|PubMed:25136834}.; PTM: N- and O-glycosylated. {ECO:0000250}.; PTM: Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading. {ECO:0000269|PubMed:9733784}.; PTM: It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.; PTM: Phosphorylation sites are present in the extracellular medium."	NX_P04004;	NP_000629.3; NM_000638.3.;
nGDVFTMPEDEYTVYDDGEEK_n145_1_T181_1_Y243_1	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."		"PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17558413, ECO:0000269|PubMed:2479556, ECO:0000269|PubMed:25136834}.; PTM: N- and O-glycosylated. {ECO:0000250}.; PTM: Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading. {ECO:0000269|PubMed:9733784}.; PTM: It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.; PTM: Phosphorylation sites are present in the extracellular medium."	NX_P04004;	NP_000629.3; NM_000638.3.;
nGDVFTMPEDEYTVYDDGEEK_n230_1_T181_1_Y243_1	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."		"PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17558413, ECO:0000269|PubMed:2479556, ECO:0000269|PubMed:25136834}.; PTM: N- and O-glycosylated. {ECO:0000250}.; PTM: Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading. {ECO:0000269|PubMed:9733784}.; PTM: It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.; PTM: Phosphorylation sites are present in the extracellular medium."	NX_P04004;	NP_000629.3; NM_000638.3.;
nGDVFTMPEDEYTVYDDGEEK_n230_1_Y243_1	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."		"PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17558413, ECO:0000269|PubMed:2479556, ECO:0000269|PubMed:25136834}.; PTM: N- and O-glycosylated. {ECO:0000250}.; PTM: Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading. {ECO:0000269|PubMed:9733784}.; PTM: It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.; PTM: Phosphorylation sites are present in the extracellular medium."	NX_P04004;	NP_000629.3; NM_000638.3.;
nQNGSNDSDRYSDNEEDSKIELK_n145_1_S167_1_Y243_1	convincing	P42167	"maybe; membrane protein, but nucleus lamina"	LAP2B_HUMAN	"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]"	TMPO LAP2	Homo sapiens (Human)	454			SUBCELLULAR LOCATION: Nucleus inner membrane; Single-pass type II membrane protein. Note=Tightly associated with the nuclear lamina.; SUBCELLULAR LOCATION: [Isoform Zeta]: Cytoplasm {ECO:0000269|PubMed:18403046}.	TRANSMEM 411..434; /note=Helical; Signal-anchor for type II membrane protein; /evidence=ECO:0000255	PTM: Mitosis-specific phosphorylation specifically abolishes its binding to lamin B and chromosomes. {ECO:0000250}.; PTM: Citrullinated by PADI4. {ECO:0000250}.	NX_P42167;	NP_001027454.1; NM_001032283.2. [P42167-1];NP_001027455.1; NM_001032284.2. [P42167-2];NP_001294904.1; NM_001307975.1.;
nRPDIQYPDATDEDITSHMESEELNGAYK_n230_1_S167_2_T181_1	convincing	P10451	convincing; known sulfotyrosines	OSTP_HUMAN	Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin)	SPP1 BNSP OPN PSEC0156	Homo sapiens (Human)	314	SIGNAL 1..16; /evidence=ECO:0000255		"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:25326458, ECO:0000269|PubMed:36213313}."		"PTM: Forms covalent cross-links mediated by transglutaminase TGM2, between a glutamine and the epsilon-amino group of a lysine residue, forming homopolymers and heteropolymers, increasing its collagen binding properties. {ECO:0000250|UniProtKB:P31096}.; PTM: Extensively phosphorylated by FAM20C in the extracellular medium at multiple sites within the S-x-E/pS motif (PubMed:15869464, PubMed:22582013, PubMed:26091039). The phosphorylated form inhibits hydroxyapatite crystallization. Dephosphorylation via a mechanism involving ALPL/TNAP promotes hydroxyapatite crystallization (By similarity). {ECO:0000250|UniProtKB:P10923, ECO:0000269|PubMed:15869464, ECO:0000269|PubMed:22582013, ECO:0000269|PubMed:26091039}.; PTM: O-glycosylated. Isoform 5 is GalNAc O-glycosylated at Thr-59 or Ser-62. {ECO:0000269|PubMed:15869464, ECO:0000269|PubMed:23234360, ECO:0000269|PubMed:25326458}."	NX_P10451;	NP_000573.1; NM_000582.2. [P10451-5];NP_001035147.1; NM_001040058.1. [P10451-1];NP_001035149.1; NM_001040060.1. [P10451-3];NP_001238758.1; NM_001251829.1.;NP_001238759.1; NM_001251830.1.;
nSLFSSEESNLGANNYDDYR_n230_1_S167_3	convincing	P04004	convincing; known sulfotyrosines	VTNC_HUMAN	Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B]	VTN	Homo sapiens (Human)	478	"SIGNAL 1..19; /evidence=ECO:0000269|PubMed:631332, ECO:0000269|PubMed:7522053"		"SUBCELLULAR LOCATION: Secreted, extracellular space {ECO:0000269|PubMed:2448300, ECO:0000269|PubMed:29567995}.; SUBCELLULAR LOCATION: Parasitophorous vacuole {ECO:0000269|PubMed:29567995}. Note=(Microbial infection) In P.falciparum-infected red blood cells, VTN internalization is detected at the early trophozoite stage (PubMed:29567995). Colocalizes with SERA5 at the schizont stage and with SERA5 P47 at the merozoite surface (PubMed:29567995). {ECO:0000269|PubMed:29567995}."		"PTM: Sulfated on tyrosine residues. {ECO:0000269|PubMed:17558413, ECO:0000269|PubMed:2479556, ECO:0000269|PubMed:25136834}.; PTM: N- and O-glycosylated. {ECO:0000250}.; PTM: Phosphorylation on Thr-69 and Thr-76 favors cell adhesion and spreading. {ECO:0000269|PubMed:9733784}.; PTM: It has been suggested that the active SMB domain may be permitted considerable disulfide bond heterogeneity or variability, thus two alternate disulfide patterns based on 3D structures are described with 1 disulfide bond conserved in both.; PTM: Phosphorylation sites are present in the extracellular medium."	NX_P04004;	NP_000629.3; NM_000638.3.;
nSLYNLGGSR_n230_1_S167_1	convincing	Q7Z794	"likely not sY; no literature evidence, although keratin sulfate is a thing this is not sY from briefly looking"	K2C1B_HUMAN	"Keratin, type II cytoskeletal 1b (Cytokeratin-1B) (CK-1B) (Keratin-77) (K77) (Type-II keratin Kb39)"	KRT77 KRT1B	Homo sapiens (Human)	578					PTM: Undergoes deimination of some arginine residues (citrullination). {ECO:0000250|UniProtKB:Q6IFZ6}.	NX_Q7Z794;	NP_778253.2; NM_175078.2.;
nVHNDAQSFDYDHDAFLGAEEAK_N115_1_n230_1_S167_1_Y243_1	convincing	O43852	"convincing; has signal peptide, linked to golgi and secreted"	CALU_HUMAN	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	Homo sapiens (Human)	315	SIGNAL 1..19; /evidence=ECO:0000269|PubMed:12665801		SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10222138}. Golgi apparatus {ECO:0000269|PubMed:10222138}. Secreted {ECO:0000305}. Melanosome {ECO:0000269|PubMed:12643545}. Sarcoplasmic reticulum lumen {ECO:0000305}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. {ECO:0000269|PubMed:12643545}.			NX_O43852;	NP_001124146.1; NM_001130674.2. [O43852-2];NP_001186600.1; NM_001199671.1. [O43852-3];NP_001186601.1; NM_001199672.1. [O43852-4];NP_001186602.1; NM_001199673.1. [O43852-10];NP_001210.1; NM_001219.4. [O43852-1];XP_016868148.1; XM_017012659.1.;
nVHNDAQSFDYDHDAFLGAEEAK_n145_1_S167_1_Y243_1	convincing	O43852	"convincing; has signal peptide, linked to golgi and secreted"	CALU_HUMAN	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	Homo sapiens (Human)	315	SIGNAL 1..19; /evidence=ECO:0000269|PubMed:12665801		SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10222138}. Golgi apparatus {ECO:0000269|PubMed:10222138}. Secreted {ECO:0000305}. Melanosome {ECO:0000269|PubMed:12643545}. Sarcoplasmic reticulum lumen {ECO:0000305}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. {ECO:0000269|PubMed:12643545}.			NX_O43852;	NP_001124146.1; NM_001130674.2. [O43852-2];NP_001186600.1; NM_001199671.1. [O43852-3];NP_001186601.1; NM_001199672.1. [O43852-4];NP_001186602.1; NM_001199673.1. [O43852-10];NP_001210.1; NM_001219.4. [O43852-1];XP_016868148.1; XM_017012659.1.;
nVHNDAQSFDYDHDAFLGAEEAK_n230_1_S167_1_Y243_1	convincing	O43852	"convincing; has signal peptide, linked to golgi and secreted"	CALU_HUMAN	Calumenin (Crocalbin) (IEF SSP 9302)	CALU	Homo sapiens (Human)	315	SIGNAL 1..19; /evidence=ECO:0000269|PubMed:12665801		SUBCELLULAR LOCATION: Endoplasmic reticulum membrane {ECO:0000269|PubMed:10222138}. Golgi apparatus {ECO:0000269|PubMed:10222138}. Secreted {ECO:0000305}. Melanosome {ECO:0000269|PubMed:12643545}. Sarcoplasmic reticulum lumen {ECO:0000305}. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV. {ECO:0000269|PubMed:12643545}.			NX_O43852;	NP_001124146.1; NM_001130674.2. [O43852-2];NP_001186600.1; NM_001199671.1. [O43852-3];NP_001186601.1; NM_001199672.1. [O43852-4];NP_001186602.1; NM_001199673.1. [O43852-10];NP_001210.1; NM_001219.4. [O43852-1];XP_016868148.1; XM_017012659.1.;
nYLSLDTEVDEENALSPEACYECK_n145_1_S167_1_Y243_1	convincing	P35556	"convincing; has signal peptide, secreted"	FBN2_HUMAN	Fibrillin-2 [Cleaved into: Placensin]	FBN2	Homo sapiens (Human)	2912	SIGNAL 1..28; /evidence=ECO:0000255		"SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:32329225}. Note=Fibrillin-2 and Placensin chains are still linked together during the secretion from cells, but are subsequently separated by furin. {ECO:0000269|PubMed:32329225}.; SUBCELLULAR LOCATION: [Fibrillin-2]: Secreted, extracellular space, extracellular matrix {ECO:0000269|PubMed:8120105}.; SUBCELLULAR LOCATION: [Placensin]: Secreted {ECO:0000269|PubMed:32329225}. Note=Secreted by placental cells. {ECO:0000269|PubMed:32329225}."		PTM: [Placensin]: N-glycosylated. {ECO:0000269|PubMed:32329225}.; PTM: O-glycosylated on serine residues by POGLUT2 and POGLUT3. {ECO:0000269|PubMed:34411563}.	NX_P35556;	NP_001990.2; NM_001999.3. [P35556-1];
